Pous, A., Izquierdo, C., Cucurull, M., Sánchez, S., Lezcano, C., Domenech, M., . . . Moran, T. (2021). Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: A case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen. Transl Lung Cancer Res.
Citação norma ChicagoPous, Anna, Cristina Izquierdo, Marc Cucurull, Silvia Sánchez, Clara Lezcano, Marta Domenech, Laia Llobera, Andrea Plaja, e Teresa Moran. "Immune-checkpoint Inhibitors for Lung Cancer Patients Amid the COVID-19 Pandemic: A Case Report of Severe Meningoencephalitis After Switching to an Extended-interval Higher Flat-dose Nivolumab Regimen." Transl Lung Cancer Res 2021.
Citação norma MLAPous, Anna, et al. "Immune-checkpoint Inhibitors for Lung Cancer Patients Amid the COVID-19 Pandemic: A Case Report of Severe Meningoencephalitis After Switching to an Extended-interval Higher Flat-dose Nivolumab Regimen." Transl Lung Cancer Res 2021.